Flat Medical Selected to Exhibit EpiFaith® for Epidural at Vizient Innovative...
TAIPEI, Taiwan Flat Medical has been selected to exhibit EpiFaith® Syringe, a visualization solution for epidural safety, at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s...
View ArticleVirpax® Pharmaceuticals宣布公开发行总额4000万美元的普通股
宾夕法尼亚州伯温 (美国商业资讯)–疼痛管理药品专业开发公司Virpax® Pharmaceuticals Inc.(“Virpax”或“公司”)...
View ArticleRio Tinto and WA Government’s Pilbara vaccination blitz commences
MELBOURNE, Australia Rio Tinto Iron Ore chief executive Simon Trott joined WA Health Minister Roger Cook today to open the Tom Price COVID-19 vaccination clinic aimed at boosting vaccination rates...
View ArticleMasimo上市单例患者使用的rainbow® SuperSensor™
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布,单例患者使用的粘贴式rainbow® SuperSensor™获得CE认证并在欧洲上市,该产品兼容Masimo和内置Masimo...
View Articleオルガノンが計画外妊娠をめぐり世界規模の対話の喚起を目指す
米ニュージャージー州ジャージーシティー (ビジネスワイヤ) — 女性向けヘルスケアの世界的企業であるオルガノン(NYSE: OGN)は、世界中で驚異的な増加を示している計画外妊娠に対する認識を高め、世界規模の対話を喚起することを目的として、公共広告(PSA)を開始します。...
View Article达沃斯阿尔茨海默病合作组织和世界经济论坛宣布全球抗击阿尔茨海默病取得重大里程碑
日内瓦 (美国商业资讯)–达沃斯阿尔茨海默病合作组织(DAC)是一个动员全世界对抗阿尔茨海默病的全球多方利益相关者合作组织。DAC今天宣布,它已接近完成基础阶段的筹资,并启动了几项关键举措,以促进阿尔茨海默病的研究、预防和护理,从而推进与该疾病的斗争。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleOrganon推出公益广告,旨在引发关于意外怀孕的全球讨论
新泽西州泽西市 (美国商业资讯)–女性健康跨国公司Organon (NYSE: OGN)推出公益广告(PSA),旨在提高人们对世界各地超高意外怀孕率的认识,并引发全球讨论。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20210924005113/zh-CN/...
View ArticleNew Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on...
TOKYO Masimo (NASDAQ: MASI) today announced the findings of a study published in the European Journal of Pediatrics in which Dr. Masashi Hotta and colleagues at the Osaka Women’s and Children’s...
View ArticleTAE Life Sciences Announces Installation of First Accelerator-based Neutron...
FOOTHILL RANCH, Calif. TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the successful...
View ArticleSunovion, Sumitomo Dainippon Pharma and Otsuka Enter Worldwide Development...
MARLBOROUGH, Mass. & OSAKA, Japan & TOKYO, Japan Sunovion Pharmaceuticals Inc. (Sunovion),its parent company Sumitomo Dainippon Pharma Co., Ltd. (Sumitomo Dainippon Pharma) and Otsuka...
View ArticleCelltrion Healthcare Showcases Positive Data on Switching and Monotherapy...
INCHEON, South Korea Celltrion Healthcare today announced two data sets relating to the use of the subcutaneous formulation of infliximab, Remsima® SC (CT-P13 SC), in inflammatory bowel disease...
View ArticleEconomic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test...
SARASOTA, Fla. Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that the Journal of Health Economics and Outcomes Research (JHEOR) has...
View ArticleSpeeDxがSARS-CoV-2 Genotyping試薬ポートフォリオの適用範囲をさらに拡充
シドニー (ビジネスワイヤ) — 革新的な分子診断ソリューションの開発を手掛けるSpeeDx Pty. Ltd.は、COVID-19変異株解析用の研究試薬の製品ラインアップをさらに拡大し、注目すべき変異株(VOI)であるSARS-CoV-2ラムダ株と関連した重要特性の変異にも対応しました。PlexPrime® SARS-CoV-2...
View ArticleHealthEdge Announces Inauguration of its India Operations Delivery Center in...
BENGALURU, India HealthEdge said today it is opening a new office Tuesday, Oct. 12, in Hinjewadi, the IT heart of Pune, with the intent to create as many as 150 new jobs in the area over the next...
View ArticleSpeeDx进一步扩大SARS-CoV-2基因分型系列试剂的检测范围
悉尼 (美国商业资讯)–创新分子诊断解决方案开发商SpeeDx Pty. Ltd.已进一步扩大其用于COVID-19变异株分析的研究试剂产品线,加入了与SARS-CoV-2拉姆达关注变异株(VOI)相关的一种关键的特征性突变。PlexPrime®...
View Article